emedicine continuing education


Frequent Questions
Notify a Colleague
About eMedicine

 

Enter your email address
to be notified when new
courses become available.



This activity is sponsored by

the Discovery Institute for

Medical Education.

 

This activity is supported by an educational grant from the

Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership.

Bristol Meyers Squibb Logo


INTRODUCTION
Peripheral arterial disease (PAD) affects more than 12 million Americans. PAD is symptomatic as intermittent claudication in 2-3% of men and 1-2 % of women older than 60 years. However, the prevalence of asymptomatic PAD, generally shown by a reduced ankle brachial index (ABI), is 3-4 times greater.

PAD is also a significant cause of hospital admission and is an important predicator of heart attack, stroke, and cardiovascular death. PAD can disrupt blood flow to arteries outside of the heart; over time, the lack of blood flow can lead to kidney failure, amputation of legs and arms, or severely high blood pressure.

The course provides a maximum of 1 AMA PRA Category 1 Credit™ and is accredited only for physicians (MD, DO, or equivalent). All other participants receive a certificate of completion.